The upregulation of the FOXA1 transcription factor network and the downregulation of the MTA3 pathway point to significant transcriptional reprogramming, consistent with reports that the MTA3 protein is often upregulated in cancers [29]. The gene discussed is FOXA1; the disease is cancer.